These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 27596118

  • 1. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
    Meng L, Xia X, Yang Y, Ye J, Dong W, Ma P, Jin Y, Liu Y.
    Int J Pharm; 2016 Nov 20; 513(1-2):8-16. PubMed ID: 27596118
    [Abstract] [Full Text] [Related]

  • 2. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F, Wang X, Xu X, Li M, Zhou J, Wang W.
    Eur J Pharm Sci; 2016 Sep 20; 92():11-21. PubMed ID: 27343697
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
    Jin X, Mo R, Ding Y, Zheng W, Zhang C.
    Mol Pharm; 2014 Jan 06; 11(1):145-57. PubMed ID: 24261922
    [Abstract] [Full Text] [Related]

  • 5. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P, Chen X, Guo R, Chen X, Chen Z, Wei C, Li Y, Wang W, Zhou Y, Qin L.
    Mol Pharm; 2020 Apr 06; 17(4):1114-1126. PubMed ID: 32176509
    [Abstract] [Full Text] [Related]

  • 6. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS, Cho CW.
    J Pharm Pharmacol; 2013 Jan 06; 65(1):72-8. PubMed ID: 23215690
    [Abstract] [Full Text] [Related]

  • 7. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH, Liu YR, Luan X, Liu HJ, Gao YG, Wu H, Fang C, Chen HZ.
    Bioconjug Chem; 2015 Aug 19; 26(8):1702-12. PubMed ID: 26076081
    [Abstract] [Full Text] [Related]

  • 8. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J, Zhao X, Chen Q, Yin X, Xin X, Li K, Qiao M, Hu H, Chen D, Zhao X.
    Acta Biomater; 2017 Mar 01; 50():381-395. PubMed ID: 27956367
    [Abstract] [Full Text] [Related]

  • 9. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W, Xi M, Duan X, Wang Y, Kong F.
    Int J Nanomedicine; 2015 Mar 01; 10():3737-50. PubMed ID: 26045664
    [Abstract] [Full Text] [Related]

  • 10. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y, Sun J, Lian H, Cao W, Wang Y, He Z.
    J Pharm Sci; 2014 May 01; 103(5):1538-47. PubMed ID: 24619562
    [Abstract] [Full Text] [Related]

  • 11. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y, Zhou C, Wei S, Yang T, Lan Y, Cao A, Yang J, Hou Y.
    Colloids Surf B Biointerfaces; 2018 Oct 01; 170():330-340. PubMed ID: 29936386
    [Abstract] [Full Text] [Related]

  • 12. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
    Baek JS, Cho CW.
    Int J Pharm; 2015 Jan 30; 478(2):617-24. PubMed ID: 25510604
    [Abstract] [Full Text] [Related]

  • 13. Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance.
    Jia L, Li Z, Shen J, Zheng D, Tian X, Guo H, Chang P.
    Int J Pharm; 2015 Jul 15; 489(1-2):318-30. PubMed ID: 25956050
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport.
    Zang X, Wang G, Cai Q, Zheng X, Zhang J, Chen Q, Wu B, Zhu X, Hao H, Zhou F.
    Drug Metab Dispos; 2018 May 15; 46(5):542-551. PubMed ID: 29523600
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.